Stem cell therapy for peripheral neuropathy is being studied because cell-based approaches may influence inflammation, blood flow, and the environment around injured peripheral nerves. Human research has focused primarily on diabetic peripheral neuropathy.
What Researchers Are Studying
- Influence inflammatory and immune-system signaling
- Affect blood flow and the environment around damaged nerves
- Be delivered safely and feasibly in carefully selected patients
- Be further evaluated for their effects on pain, sensation, nerve function, and quality of life
Peripheral neuropathy includes conditions with different causes, including diabetic neuropathy, chemotherapy-related neuropathy, nerve compression, autoimmune neuropathy, and inherited neuropathies. Researchers are studying how different cell products and treatment approaches may apply to these conditions.
Note: Stem cell therapies for peripheral neuropathy are not FDA-approved and are investigational. Research findings do not guarantee individual results.
How Stem Cell Therapy for Neuropathy Is Being Studied
Most clinical research has evaluated cell-based treatments in people with diabetic peripheral neuropathy. Studies use different cell products, preparation methods, doses, delivery routes, background diabetes treatment plans, and outcome measures. Researchers may assess pain, sensation, nerve-conduction testing, blood flow, ulcer healing, or quality of life. This work is helping identify the approaches and patient groups that warrant continued clinical study. Stem cell treatment for neuropathy remains investigational.